Why did 4596.T stock spike on 06 Feb 2026?

The spike followed heavy buying and a volume surge to 21,719,400.00 shares. Market interest tied to pipeline updates and the upcoming earnings announcement on 2026-02-13 pushed the price to JPY 148.00.

What is Meyka AI’s view for 4596.T stock?

Meyka AI rates 4596.T at **68.27** (Grade B, HOLD). The forecast model gives monthly **JPY 98.52**, quarterly **JPY 53.84**, and yearly **JPY 10.75**. These are model projections and not guarantees.

What are the main risks for 4596.T stock investors?

Primary risks include negative earnings (EPS -19.46), binary clinical-trial outcomes for emixustat, small float volatility, and the potential for steep downside if trials disappoint.

What should traders watch next for 4596.T stock?

Monitor the earnings announcement on 2026-02-13, any clinical or regulatory updates on emixustat, and daily volume versus the 50-day average of 56.34 to judge follow-through.

JP Stocks

4596.T stock +34.55% to JPY 148 on 06 Feb 2026 market closed: watch volume spike

ByDanny Kontos February 6, 2026

The 4596.T stock surged 34.55% to JPY 148.00 at the JPX market close on 06 Feb 2026, led by a volume jump to 21,719,400.00 shares versus an average of 3,699,918.00. The move followed renewed interest in Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) after clinical and corporate updates and comes ahead of an earnings update on 2026-02-13. Traders should note the company trades well above its 50-day average of JPY 56.34 and 200-day average of JPY 55.03, which signals short-term momentum in a small-cap biotech listed on JPX in Japan.